Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America.
about
Interventions for tobacco use cessation in people living with HIV and AIDSHuman Immunodeficiency Virus as a Chronic Disease: Evaluation and Management of Nonacquired Immune Deficiency Syndrome-Defining ConditionsCommunicable and non-communicable diseases: connections, synergies and benefits of integrating care.Non-cigarette tobacco and poly-tobacco use among persons living with HIV drawn from a nationally representative sampleNarrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to CareTobacco use among people living with HIV: analysis of data from Demographic and Health Surveys from 28 low-income and middle-income countries.The Usefulness of the CRAFFT in Screening for Problematic Drug and Alcohol Use Among Youth Living with HIV.Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment.Routine Eye Screening by an Ophthalmologist Is Clinically Useful for HIV-1-Infected Patients with CD4 Count Less than 200 /μLWhat Triggers a Diagnosis of HIV Infection in the Tokyo Metropolitan Area? Implications for Preventing the Spread of HIV Infection in Japan.Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors.Tobacco Use, Use Disorders, and Smoking Cessation Interventions in Persons Living With HIV.Psychosocial correlates of nutritional status among people living with HIV on antiretroviral therapy: A matched case-control study in Central zone of Tigray, Northern Ethiopia.Population-Based Estimates of Life Expectancy After HIV Diagnosis: United States 2008-2011.Pathophysiology and management of cardiovascular disease in patients with HIVAnalysis of contemporary HIV/AIDS health care costs in Germany: Driving factors and distribution across antiretroviral therapy lines.Recent Tobacco Smoking is Associated with Poor HIV Medical Outcomes Among HIV-Infected Individuals in New York.Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population.[Causes of death in patients with HIV infection in two Tunisian medical centers].Effect of Tenofovir Disoproxil Fumarate on Incidence of Chronic Kidney Disease and Rate of Estimated Glomerular Filtration Rate Decrement in HIV-1-Infected Treatment-Naïve Asian Patients: Results from 12-Year Observational Cohort.Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis.Qualitative exploration of a smoking cessation trial for people living with HIV in South Africa.Characteristics of intermittent smokers and their association with quit intentions in a sample of heavy-drinking HIV-infected men who have sex with men.HIV and ageing: improving quantity and quality of life.Respiratory symptoms in people living with HIV and the effect of antiretroviral therapy: a systematic review and meta-analysis.Sex Differences in Tobacco Use Among Persons Living With HIV/AIDS: A Systematic Review and Meta-Analysis.Immunosenescence and hurdles in the clinical management of older HIV-patients.Impact of Cigarette Smoking and Smoking Cessation on Life Expectancy Among People With HIV: A US-Based Modeling Study.The changing face of an epidemic: healthy old age with HIV.Routine monitoring and assessment of adults living with HIV: results of the British HIV Association (BHIVA) national audit 2015.Prevalence of self-reported comorbidities in HIV positive and HIV negative men who have sex with men over 55 years-The Australian Positive & Peers Longevity Evaluation Study (APPLES).Conjunctival Flora of Human Immunodeficiency Virus Patients on Antiretroviral Treatment.Cardiovascular risk and dyslipidemia among persons living with HIV: a review.Respiratory health status is impaired in UK HIV-positive adults with virologically suppressed HIV infection.Prevalence of Substance Use in an HIV Primary Care Safety Net Clinic: A Call for Screening.Cigarette Smoking and Inflammation, Monocyte Activation, and Coagulation in HIV-Infected Individuals Receiving Antiretroviral Therapy, Compared With Uninfected Individuals.Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): The Study Protocol of an Uncontrolled Feasibility Study of Novel Nicotine Replacement Products among People Living with HIV Who Smoke.Lung Cancer Mortality Associated With Smoking and Smoking Cessation Among People Living With HIV in the United States.Perceived risks and benefits of quitting smoking in a sample of adults living with HIV/AIDS.Knowledge about nicotine among HIV-positive smokers: Implications for tobacco regulatory science policy.
P2860
Q26471480-4C19C459-ADF1-4E3B-81E6-75641D55901FQ26740117-9433DED4-58E6-41E9-86A2-8413E26968A6Q30387611-A363C4D3-1B98-4773-9AA6-DD135926137CQ30743487-7BC1AAF0-08A6-4920-8D46-679508351769Q33668524-AE490A5D-A4C3-4EBC-A005-10E18BF1A536Q33711008-3B04C4C3-6E8E-4BC4-B419-14432F14AC45Q33803835-2CECE6D3-3982-40F2-9DF5-5066E263FCC2Q33880782-0FF57E01-5B42-4378-A9CE-0D92A380B3AAQ35777009-46E26AE9-2105-4DBF-B3BE-E32A973DC378Q35852492-90BCD161-4CA2-4354-8EE5-7A9266CEDB59Q36063953-01D778C1-10B0-478B-B295-1D6BFB6F7B51Q36275850-CDCA5B4A-0AD2-4A1B-BD8F-176EA6D92021Q36310848-711463D9-60CF-4880-9980-2B20217B7EC2Q36925430-58DBDD21-C789-404B-82DF-5863B61A04CBQ37038775-A1A5882E-2101-41E1-A71B-80876BBD652BQ37077894-1B3367A8-7F98-4DC5-94B4-D1359BE9E6D5Q37088838-500806B2-D586-45AC-B738-E23BBB102CEFQ37636104-E89FF7DC-9497-4D30-83DB-8721599D7B62Q37665837-A229B586-AEAD-486C-ADBD-7A2B7D1DEA36Q37713060-1351FBAB-CBFA-4D56-BEEA-92B891324A67Q38405857-FF7040DA-BAB5-4537-939F-EF4158B1CD86Q38668397-4C07AF5A-E8B0-4678-BB60-EFE079C2FFEBQ38815916-6C647BCB-059F-44BF-85F4-E3F5CF2FFE49Q38883328-FFAFECAD-D6F5-4973-9E21-9471C35D2156Q39037971-01D760FB-E9E9-4791-9821-742AD788DF47Q39046688-B9DA089A-CBDD-43AC-B967-B7B19C6BFE0EQ39170367-201EA862-7470-4B61-99E4-B31269D3961AQ39213747-C1AF7BAC-1BC9-49FD-83DF-BACB549692ABQ40045681-A966C254-FD2D-44DD-B59C-92BA3D799648Q40048428-B70600F3-3D29-439E-A7B4-998C821F2AEEQ40060225-CC3BFDED-1EC1-447D-BC68-90DAB36B317AQ40080705-3EC96A2E-3CC3-42A4-81CA-44736240C08EQ40100018-779CD3D0-8AAC-4845-BDB0-7AA09D51499FQ40292019-EA5A6177-CCD4-4D5A-921C-03AC96F6AB0AQ40344047-CF65C1D3-3D45-4EBD-9983-F0D7F9074F40Q40523298-8131B481-6248-4401-8B11-49B90580218BQ41338916-6DC899ED-1C41-4A11-AD9F-185BC529030CQ41925024-D4C9EF1D-A6F3-4B55-AC6C-C773AF05E538Q41991382-5775B68A-00B1-4265-BDF3-811F8F0A5580Q45946187-4C5FB6E4-6409-4414-813A-86BD08D531E1
P2860
Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Smoking and life expectancy am ...... y in Europe and North America.
@ast
Smoking and life expectancy am ...... y in Europe and North America.
@en
Smoking and life expectancy am ...... y in Europe and North America.
@nl
type
label
Smoking and life expectancy am ...... y in Europe and North America.
@ast
Smoking and life expectancy am ...... y in Europe and North America.
@en
Smoking and life expectancy am ...... y in Europe and North America.
@nl
prefLabel
Smoking and life expectancy am ...... y in Europe and North America.
@ast
Smoking and life expectancy am ...... y in Europe and North America.
@en
Smoking and life expectancy am ...... y in Europe and North America.
@nl
P2093
P2860
P50
P1433
P1476
Smoking and life expectancy am ...... y in Europe and North America.
@en
P2093
Antonella d'Arminio
Colette Smith
Jonathan A C Sterne
Margaret T May
Peter Reiss
Suzanne M Ingle
P2860
P304
P356
10.1097/QAD.0000000000000540
P407
P50
P577
2015-01-01T00:00:00Z